Saturday, January 23, 2010

Pay-For-Delay Phamaceutical Deals

From: jrmaddog@aol.com
Date: Sat, 23 Jan 2010 21:12:48 EST
Subject: Pay-For-Delay
To: edit.cen@acs.org


C&EN Editor,

RE: Questioned Deals In Europe, C&ENews, 88(3), January 18, 2010, p6. &

FTC Seeks Ban On Pay-For-Delay Deals, C&ENews, 88(3), January 18, 2010, p22.

When an individual offers to not release information about another individual in exchange for money (e.g., the David Letterman incident), it is called extortion.

When a generic pharmaceutical maker agrees to not release its own, legal product in exchange for money from the original patent holder, it is called business.

What am I missing?


Regards,
J. R. Madden

No comments: